Benchmark Reiterates Speculative Buy on Orgenesis, Maintains $6 Price Target
BenzingaJun 14, 2023 06:52
Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Orgenesis (ORGS) and BELLUS Health (BLU)
TipRanksMar 22, 2023 11:37
No Data